The International Esophageal Squamous Cell Carcinoma Consortium (IESC3) was officially introduced during two major cancer research meetings held on May 14th and 15th, 2025. The consortium aims to unite researchers and studies worldwide to accelerate advancements in understanding and combating esophageal squamous cell carcinoma (ESCC).
The first presentation took place in person at the annual Stomach Cancer Pooling Project (STOP) meeting in Milan, Italy, where leading experts gathered to discuss the latest findings in stomach and related risk factors. The consortium’s representatives shared the mission and goals of IESC3, highlighting the potential benefits of global collaboration in research efforts against ESCC. Following the in-person event, the consortium also presented virtually at The International Head and Neck Cancer Epidemiology (INHANCE) Consortium meeting, which was conducted online.
The IESC3 leadership (Prof. Paolo Boffetta) emphasized the importance of collaboration across disciplines and regions to enhance data sharing, harmonize research protocols, and foster large-scale studies. They extended an open invitation to interested parties and ongoing studies to become part of this global network dedicated to improving prevention, diagnosis, and treatment of esophageal squamous cell carcinoma.
For more information about the STOP and INHANCE consortiums you can visit the consortium’s official websites.
